SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Yu-Jeong,Choi ^[1] ; Kangwook,Lee ^[2] ; Ji-Hye,Yoon ^[3] ; Sung-Gook,Cho ^[4] ; Yun-Gyeong,Kim ^[4] ; Miso,Jeong ^[1] ; Hyun-Ha,Hwang ^[1] ; Seo Yeon,Lee ^[1] ; Se-Eun,Jung ^[1] ; Seong-Gyu,Ko ^[1]

作者单位： Department of Science in Korean Medicine, Graduate School, Kyung Hee University, 26 Kyungheedae Rd., Dongdaemun-gu, Seoul 02447, Republic of Korea. ^[1] Institute of Safety and Effectiveness Evaluation for Korean Medicine, 26 Kyungheedae Rd., Dongdaemun-gu, Seoul 02447, Republic of Korea. ^[2] Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, 26 Kyungheedae Rd., Dongdaemun-gu, Seoul 02447, Republic of Korea. ^[3] Department of Biotechnology, Korea National University of Transportation, 61 University Rd., Jeungpyeong, Chungbuk 27909, Republic of Korea. ^[4]

主题词血管生成抑制剂(Angiogenesis Inhibitors);动物(Animals);细胞凋亡(Apoptosis);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);人类(Humans);小鼠(Mice)

DOI 10.1155/2022/3647900

PMID 35572726

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

BioMed research international

2022年2022卷

3647900页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer.

BioMed research international

相似文献

BioMed research international

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer.

BioMed research international

相似文献

BioMed research international

相关期刊

检索历史清除